The outcomes of indocyanine green angiography monitored immunotherapy in Vogt-Koyanagi-Harada disease

British Journal of Ophthalmology

Volumn 97, Issue 2, 2013, Pages 130-133

  Chee, Soon Phaik ^a,b,c,d   Jap, Aliza ^a,e  

^a SINGAPORE NATIONAL EYE CENTRE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c DUKE NUS MEDICAL SCHOOL   (Singapore)

^d SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^e CHANGI GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; INDOCYANINE GREEN; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; DRUG MEGADOSE; EYE FUNDUS; FEMALE; HUMAN; IMMUNOTHERAPY; INDOCYANINE GREEN ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SINGAPORE; TREATMENT DURATION; VISION; VISUAL ACUITY; VOGT KOYANAGI SYNDROME;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; COLORING AGENTS; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; FUNDUS OCULI; GLUCOCORTICOIDS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; INDOCYANINE GREEN; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; UVEOMENINGOENCEPHALITIC SYNDROME; VISUAL ACUITY; YOUNG ADULT;

EID: 84872954106     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-302538     Document Type: Article

References (26)

1. Kitaichi N, Horie Y, Ohno S. Prompt therapy reduces the duration of systemic corticosteroids in Vogt-Koyanagi-Harada disease. Graefes Arch Clin Exp Ophthalmol 2008;246:1641-2.
2. Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy and long-term visual outcome. Arch Ophthalmol 1991;109:682-7.
3. Sasamoto Y, Ohno S, Matsuda H. Studies on corticosteroid therapy in Vogt- Koyangi-Harada disease. Ophthalmologica 1990;201:162-7. (Pubitemid 20343836)
4. Kawaguchi T, Horie S, Bouchenaki N, et al. Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease. Int Ophthalmol 2010;30:41-50.
5. Chee SP, Jap A, Bacsal K. Spectrum of Vogt-Koyanagi-Harada disease in Singapore. Int Ophthalmol 2007;27:137-42. (Pubitemid 46909253)
6. Read RW, Rechodouni A, Butani N, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001;131:599-606. (Pubitemid 32422116)
7. Al-Kharashi AS, Aldibhi H, Al-Fraykh H., et al Prognostic factors in Vogt-Koyanagi- Harada disease. Int Ophthalmol 2007;27:201-10. (Pubitemid 46909262)
8. Lai TY, Chan RP, Chan CK, et al. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. Eye 2009;23:543-8.
9. Bouchenaki N, Herbort CP. The contribution of indocyanine green angiography to the appraisal and management of Vogt-Koyanagi-Harada disease. Ophthalmology 2001;108:54-64. (Pubitemid 32059537)
10. Herbort CP, Mantovani A, Bouchenaki N. Indocyanine green angiography in Vogt- Koyanagi-Harada disease: angiographic signs and utility in patient follow-up. Int Ophthalmol 2007;27:173-82. (Pubitemid 46909258)
11. Okada AA, Mizusawa T, Sakai J, et al. Videofunduscopy and videoangiography using the scanning laser ophthalmoscope in Vogt-Koyanagi-Harada syndrome. Br J Ophthalmol 1998;82:1175-81.
12. Keino H, Goto H, Usui M. Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation. Graefes Arch Clin Exp Ophthalmol 2002;240:878-82. (Pubitemid 36075647)
13. Chee SP, Yeo YSI. Peripapillary atrophy in Vogt-Koyanagi-Harada syndrome. In: Ohno S, Aoki K, Usui M, Usui E. eds. Uveitis Today-Excerpta Medica International Congress Series 1158. Amsterdam: Elsevier, 1998:181-4.
14. Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt- Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;131:647-52. (Pubitemid 32422124)
15. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000;130:492-513.
16. Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 2005;140:509-16. (Pubitemid 41224845)
17. Jap A, Luu CD, Yeo I, et al. Correlation between peripapillary atrophy and corticosteroid therapy in patients with Vogt-Koyanagi-Harada disease. Eye 2008;22:240-5. (Pubitemid 351266465)
18. Bouchenaki N, Herbort CP. Indocyanine green angiography guided management of Vogt-Koyanagi-Harada disease. J Ophthalmic Vis Res 2011;6:241-8.
19. Chee SP, Luu CD, Cheng CL, et al. Visual function in Vogt-Koyanagi-Harada patients. Graefes Arch Clin Exp Ophthalmol 2005;243:785-90. (Pubitemid 41300420)
20. da Silva FT, Hirata CE, Olivalves E, et al. Fundus-based and electroretinographic strategies for stratification of late-stage Vogt-Koyanagi-Harada disease patients. Am J Ophthalmol 2009;148:939-45.
21. Sonoda S, Nakao K, Ohba N. Extensive chorioretinal atrophy in Vogt-Koyanagi- Harada disease. Jpn J Ophthalmol 1999;43:113-19. (Pubitemid 29225334)
22. Fong AH, Li KK, Wong D. Choroidal evaluation using enhanced depth imaging spectral-domain optical coherence tomography in Vogt-Koyanagi-Harada disease. Retina 2011;31:502-9.
23. Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina 2011;31:510-17.
24. Nakai K, Gomi F, Ikuno Y, et al. Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography. Graefes Arch Clin Exp Ophthalmol 2012;250:1089-95.
25. Yang P, Fang W, Wang L, et al. Study of macular function by multifocal electroretinography in patients with Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 2008;146:767-71.
26. Hirose S, Saito W, Yoshida K, et al. Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease. Acta Ophthalmol 2008;86:902-7.